FBInvestor
Stocks / Gilead Sciences Inc
Institutional Ownership

Gilead Sciences Inc

CUSIP 375558103COMGILDQ1 2026

13D / 13G Filings
21
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
10.5%
Max % of class reported
Institutional Holders
2,284
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

21 filings · latest Feb 5, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 5, 2026Fmr LLC13G5.3%65.54MSEC
2May 13, 2025Capital World Investors13G/A4.3%53.83MSEC
3Apr 24, 2025Blackrock, Inc.13G/A8.2%101.74MSEC
4Feb 13, 2024Vanguard Group Inc13G/A9.0%111.82MSEC
5Feb 9, 2024Capital World Investors13G/A6.7%83.70MSEC
6Jan 24, 2024Blackrock Inc.13G/A9.9%122.79MSEC
7Feb 13, 2023Capital World Investors13G5.5%68.90MSEC
8Feb 13, 2023Capital Research Global Investors13G/A4.4%54.60MSEC
9Feb 9, 2023Vanguard Group Inc13G/A8.9%112.04MSEC
10Jan 31, 2023Blackrock Inc.13G/A10.5%131.56MSEC

11 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Gilead Sciences Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Blackrock, Inc.119.01M$16.59B
2Fmr LLC71.91M$10.02B
3State Street Corp59.86M$8.34B
4Capital World Investors41.28M$5.75B
5Jpmorgan Chase & Co33.99M$4.63B
6Geode Capital Management, LLC29.73M$4.14B
7Capital Research Global Investors27.13M$3.78B
8Dodge & Cox24.25M$3.38B
9Morgan Stanley23.30M$3.25B
10Bank Of America Corp /De/19.98M$2.78B